The advent of fluid resuscitation appears to date back to 1832 in response to a cholera outbreak in England.1 Crystalloid solutions have predominantly been used as initial resuscitative fluids in critically ill patients. Since the first clinical use of a human albumin solution was documented in 1941,2 clinicians and researchers have evaluated the use of albumin and other colloids as compared with crystalloids. Albumin has fallen out of favor for some clinicians because of the lack of clinical benefits over crystalloids in multiple large randomized controlled trials and the cost of albumin compared with alternative fluids.3–5 With over 35% of patients receiving fluid resuscitation on any given day in the intensive care unit,6 understanding the nuances between resuscitative fluids is paramount to caring for the critically ill patient because no ideal fluid exists. The purposes of this article are to review the role of...
Skip Nav Destination
Article navigation
Fall 2022
Drug Update|
September 15 2022
Use of Albumin as a Resuscitative Fluid in the Intensive Care Unit
Nicolas Tran, PharmD, BCPS;
Nicolas Tran, PharmD, BCPS
Nicolas Tran is Postgraduate Year 2 Critical Care Pharmacy Resident, Department of Pharmacy Services, Tampa General Hospital, PO Box 1289, Tampa, FL 33601-1289 ([email protected]).
Search for other works by this author on:
Christopher Allen, PharmD
Christopher Allen, PharmD
Christopher Allen is Clinical Pharmacist – Trauma Surgical Critical Care, Department of Pharmacy Services, Tampa General Hospital, Tampa, Florida.
Search for other works by this author on:
AACN Adv Crit Care (2022) 33 (3): 233–239.
Citation
Nicolas Tran, Christopher Allen; Use of Albumin as a Resuscitative Fluid in the Intensive Care Unit. AACN Adv Crit Care 15 September 2022; 33 (3): 233–239. doi: https://doi.org/10.4037/aacnacc2022946
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
162
Views